A protein tyrosine phosphatase inhibitor, pervanadate, inhibits angiotensin II-Induced β-arrestin cleavage

Molecules and Cells

Volumn 28, Issue 1, 2009, Pages 25-30

  Jang, Sei Heon ^a   Hwang, Si Ae ^a   Kim, Mijin ^a   Yun, Sung Hae ^b,d   Kim, Moon Sook ^b   Karnik, Sadashiva S ^c   Lee, ChangWoo ^a  

^a Daegu University   (South Korea)

^b Deagu Science High School   (South Korea)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Yonsei University   (South Korea)

Author keywords

arrestin; Angiotensin AT1 receptor; Orthovanadate; Pervanadate; Protein tyrosine phosphatase

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; BETA ARRESTIN; GREEN FLUORESCENT PROTEIN; MOLYBDIC ACID; OKADAIC ACID; ORTHOVANADIC ACID; PERVANADATE; PROTEIN TYROSINE PHOSPHATASE; PYROPHOSPHATE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; ANIMALS; ARRESTINS; BLOTTING, WESTERN; CERCOPITHECUS AETHIOPS; COS CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GREEN FLUORESCENT PROTEINS; HYDROLYSIS; MOLYBDENUM; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN TYROSINE PHOSPHATASES; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; TRANSFECTION; TYROSINE; VANADATES; VASOCONSTRICTOR AGENTS;

EID: 69849084583     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10059-009-0104-1     Document Type: Article

References (19)

1. Azarian, S.M., King, A.J., Hallett, M.A., and Williams, D.S. (1995). Selective proteolysis of arrestin by calpain. Molecular characteristics and its effect on rhodopsin dephosphorylation. J. Biol. Chem. 270, 24375-24384.
2. Barak, L.S., Ferguson, S.S., Zhang, J., and Caron, M.G. (1997). A β-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation. J. Biol. Chem. 272, 27497-27500.
3. Brautigan, D.L., and Pinault, F.M. (1993). Serine phosphorylation of protein tyrosine phosphatase (PTP1B) in HeLa cells in response to analogues of cAMP or diacylglycerol plus okadaic acid. Mol. Cell. Biochem. 127, 121-129.
4. Eguchi, S., Dempsey, P.J., Frank, G.D., Motley, E.D., and Inagami, T. (2001). Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J. Biol. Chem. 276, 7957-7962.
5. Garton, A.J., and Tonks, N.K. (1994). PTP-PEST: A protein tyrosine phosphatase regulated by serine phosphorylation. EMBO J. 13, 3763-3771.
6. Han, M., Gurevich, V.V., Vishnivetskiy, S.A., Sigler, P.B., and Schubert, C. (2001). Crystal structure of β-arrestin at 1.9 A: possible mechanism of receptor binding and membrane translocation. Structure (Camb) 9, 869-880.
7. Krupnick, J.G., Goodman, O.B., Jr., Keen, J.H., and Benovic, J.L. (1997). Arrestin/clathrin interaction. Localization of the clathrin binding domain of nonvisual arrestins to the carboxy terminus. J. Biol. Chem. 272, 15011-15016.
8. Lee, C., Hwang, S.A., Jang, S.H., Chung, H.S., Bhat, M.B., and Karnik, S.S. (2007). Manifold active-state conformations in GPCRs: agonist-activated constitutively active mutant AT1 receptor preferentially couples to Gq compared to the wild-type AT1 receptor. FEBS Lett. 581, 2517-2522.
9. Lee, C., Bhatt, S., Shukla, A., Desnoyer, R.W., Yadav, S.P., Kim, M., Jang, S.H., and Karnik, S.S. (2008). Site-specific cleavage of G protein-coupled receptor-engaged β-arrestin: Influence of the AT1 receptor conformation on scissile site selection. J. Biol. Chem. 283, 21612-21620.
10. Lefkowitz, R.J., and Shenoy, S.K. (2005). Transduction of receptor signals by β-arrestins. Science 308, 512-517.
11. Lin, F.T., Krueger, K.M., Kendall, H.E., Daaka, Y., Fredericks, Z.L., Pitcher, J.A., and Lefkowitz, R.J. (1997). Clathrin-mediated endocytosis of the β-adrenergic receptor is regulated by phosphorylation/ dephosphorylation of β-arrestin1. J. Biol. Chem. 272, 31051-31057.
12. Marrero, M.B., Paxton, W.G., Schieffer, B., Ling, B.N., and Bernstein, K.E. (1996). Angiotensin II signalling events mediated by tyrosine phosphorylation. Cell. Signal. 8, 21-26.
13. Marrero, M.B., Venema, V.J., Ju, H., Eaton, D.C., and Venema, R.C. (1998). Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: Roles of SHP-1 and SHP-2. Am. J. Physiol. 275, C1216-1223.
14. Nobles, K.N., Guan, Z., Xiao, K., Oas, T.G., and Lefkowitz, R.J. (2007). The active conformation of β-arrestin1: Direct evidence for the phosphate sensor in the N-domain and conformational differences in the active states of β-arrestins 1 and 2. J. Biol. Chem. 282, 21370-21381.
15. Oro, C., Qian, H., and Thomas, W.G. (2007). Type 1 angiotensin receptor pharmacology: Signaling beyond G proteins. Pharmacol. Ther. 113, 210-226.
16. Pugazhenthi, S., Tanha, F., Dahl, B., and Khandelwal, R.L. (1996). Inhibition of a Src homology 2 domain containing protein tyrosine phosphatase by vanadate in the primary culture of hepatocytes. Arch. Biochem. Biophys. 335, 273-282.
17. Strack, V., Krutzfeldt, J., Kellerer, M., Ullrich, A., Lammers, R., and Haring, H.U. (2002). The Protein-tyrosine-phosphatase SHP2 is phosphorylated on serine residues 576 and 591 by protein kinase C isoforms α, β1, β2, and ν. Biochemistry 41, 603-608.
18. Vishnivetskiy, S.A., Paz, C.L., Schubert, C., Hirsch, J.A., Sigler, P.B., and Gurevich, V.V. (1999). How does arrestin respond to the phosphorylated state of rhodopsin? J. Biol. Chem. 274, 11451-11454.
19. Xiao, K., Shenoy, S.K., Nobles, K., and Lefkowitz, R.J. (2004). Activation-dependent conformational changes in β-arrestin 2. J. Biol. Chem. 279, 55744-55753.